ThermoBreast - Non-contact Breast Cancer Imaging Using AI-enhanced Thermography.

Inclusion criteria * Screening cohort * Female subjects aged 40 to 74 years old (inclusive) presenting for routine mammography/tomosynthesis breast cancer screening according to national/regional guidelines * Subjects who are willing to give written informed consent for study participation * Subjects who are able to understand the character and individual consequences of the clinical trial and who are ready to comply with the study related visits and procedures * High-risk screening cohort * Female subjects aged 18 and above presenting for intensified high-risk breast cancer screening due to genetic predisposition or family history according to national/regional guidelines * Subjects who are willing to give written informed consent for study participation * Subjects who are able to understand the character and individual consequences of the clinical trial and who are ready to comply with the study related visits and procedures * Diagnostics cohort * Female subjects aged 18 and above presenting for intensified aftercare after a history of breast cancer, patients with symptoms (nipple discharge, breast lump based on physician physical exam or self-breast exam), patients who were referred for additional examination (MRI, Ultrasound, fine-needle aspiration cytology (FNAC) or biopsy) based on suspicious imaging findings in either breast * Subjects who are willing to give written informed consent for study participation * Subjects who are able to understand the character and individual consequences of the clinical trial and ready to comply with the study related visits and procedures Exclusion Criteria • (High-risk) Screening and Diagnostics cohort * Subjects who are pregnant or lactating * Subjects who have undergone lumpectomy or mastectomy in the last 4 months at the time of study enrollment * Subjects who have undergone cancer therapy (chemotherapy, start of hormonal therapy, radiotherapy, surgery) in the last 4 months at the time of study enrollment * Subjects who have undergone a breast biopsy in the last 2 months at the time of study enrollment * No subject will be allowed to enrol in this trial more than once.